Make every conference count
For life science organizations, scientific, medical, and patient advocacy conferences are much more than dates on a calendar. They are opportunities to share data, engage with key opinion leaders (KOLs),…
Make every conference count
Medical publications are evolving. Is your organization?
In many pharmaceutical and biotechnology companies, publications and medical communications teams are no longer viewed as executional functions responsible solely for delivering manuscripts, congress presentations, and publication plans. They’re increasingly expected to be strategic partners. That…
When Should Quality Control Occur in Regulatory Writing? More Often Than You Think.
One of the most common misconceptions in regulatory writing is that quality control (QC) happens after a document is complete. In reality, waiting until the final review to identify issues…
Staff Spotlight: Mary Ellis Bogden, Associate Director, Regulatory Writing Services
Mary Ellis Bogden joined Med Communications earlier this year as Associate Director, Regulatory Writing Services. When it comes to navigating complex regulatory pathways and bringing therapies closer to patients, few…
What’s the biggest challenge in building a Scientific Platform?
Building a Scientific Platform is one of the most valuable activities in Medical Affairs, but it is rarely the easiest. The biggest challenges often don’t involve the science itself. They’re…
Breaking Down the Common Technical Document (CTD): Where Does Regulatory Writing Fit?
The Common Technical Document (CTD) is the foundation of regulatory submissions worldwide. While many view it as a collection of documents, regulators see it as one integrated story supporting a…
August is National Immunization Awareness Month
Each August, during National Immunization Awareness Month, we recognize the vital role vaccines play in protecting individuals and communities from infectious diseases. Timely immunizations help safeguard those most at risk,…
Medical Publications Are Evolving. Is Your Organization?
The greatest risk to your scientific narrative isn’t poor science—it’s inconsistency
Every year, medical communications teams invest significant resources generating high-quality evidence through publications, congress presentations, advisory boards, and clinical research. Yet as that evidence is translated into HCP materials, field…
How efficient is your content review process?
For pharmaceutical, biotech, and medical device organizations, every review delay can impact campaign timelines, product communications, and stakeholder engagement. The challenge isn’t just reviewing content. It’s doing so efficiently while…